Patients with DCAF4L2 alteration in tumor tissue occupied a larger proportion of MSI‐type GC with a significantly higher average MSI MANTIS Score compared to those unaltered ones, which was in consistent with the pattern in our cohort (Figure 5D,E and Figure S5C). This evidence concerns the gene DCAF4L2 and neoplasm.